| DSM–IV |
phenotype |
2 |
1 |
|
| DSM-IV alcohol dependence |
phenotype |
26 |
16 |
AD, AD criterion count, Alcohol Dependence, Alcohol Dependence (DSM-IV), Alcohol dependence, Alcohol dependence (DSM-IV), DSM-IV AD, DSM-IV AD diagnosis, DSM-IV AD symptoms, DSM-IV Alcohol Dependence, DSM-IV alcohol dependence, DSM-IV diagnosis of alcohol dependence, DSM-IV lifetime alcohol dependence, alcohol dependence, alcohol dependence symptom count |
| DSM-IV alcohol use disorder |
phenotype |
4 |
1 |
AUD criteria, DSM-IV, DSM-IV AUD, DSM-IV alcohol use disorder criteria, DSMIV alcohol use disorder |
| DSM-IV cannabis abuse |
phenotype |
2 |
2 |
|
| DSM-IV cannabis dependence |
phenotype |
3 |
2 |
|
| DSM-IV nicotine dependence |
phenotype |
3 |
— |
nicotine dependence |
| DSM-IV psychiatric disorders |
phenotype |
2 |
2 |
|
| DTI |
drug |
2 |
2 |
DTI data, diffusion tensor imaging |
| DTNBP1 |
gene |
4 |
4 |
Dystrobrevin-binding protein-1, dysbindin |
| DTT |
drug |
8 |
2 |
dithiothreitol |
| Dual Luciferase Reporter Assay System |
drug |
2 |
— |
Promega Dual Luciferase Reporter Assay System |
| DUD |
phenotype |
2 |
2 |
DUD risk, drug use disorder |
| Duke Neurogenetics Study |
cohort |
2 |
2 |
DNS |
| Dulbecco's Modified Eagle Medium |
drug |
2 |
— |
DMEM, Dulbecco’s modified medium |
| duplex sequencing |
drug |
2 |
— |
DS |
| duplication |
variant |
11 |
5 |
duplications |
| Duration |
phenotype |
2 |
2 |
duration, duration of alcohol use |
| duration of smoking |
phenotype |
4 |
3 |
duration, time since beginning to smoke daily |
| Dutch sample |
cohort |
4 |
1 |
Dutch cohort |
| Dutch twins |
cohort |
2 |
1 |
Dutch twin cohort |
